Sagefield Capital’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Sagefield Capital’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-37,700	Closed	-$372K	–	157
2022 Q2	$372K	Hold	37,700	–	–	0.17%	74
2022 Q1	$371K	Hold	37,700	–	–	0.16%	79
2021 Q4	$368K	Buy	+37,700	New	+$369K	0.17%	72

Other funds holding FLAC

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

Sagefield Capital's FLAC Position: Q3 2022 in Review

Sagefield Capital sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q3 2022, closing a stake of 37,700 shares — an estimated $372K sold.

Sagefield Capital first reported a position in FLAC in Q4 2021 and held it in 3 quarters. The position peaked at $372K in Q2 2022. 52 funds tracked by Wall St. Rank hold FLAC as of Q3 2022.

Sagefield Capital reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Sagefield Capital sold 37,700 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q3 2022, an estimated $372K.
Sagefield Capital first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q4 2021 and held it in 3 quarters.
Sagefield Capital's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $372K in Q2 2022.
52 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q3 2022.

Based on Sagefield Capital's 13F filing for Q3 2022, filed 14 Nov 2022.